UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells

Gynecological endocrinology, 2013-02, Vol.29 (2), p.160-162

2013

Volltextzugriff (PDF)

The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells

European journal of obstetrics & gynecology and reproductive biology, 2006-11, Vol.129 (1), p.77-83

2006

Volltextzugriff (PDF)

The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model

Maturitas, 2017-08, Vol.102, p.26-33

2017

Volltextzugriff (PDF)

Membrane-initiated effects of Serelys ® on proliferation and apoptosis of human breast cancer cells

Gynecological endocrinology, 2018-04, Vol.34 (4), p.353-356

2018

Volltextzugriff (PDF)

The pharmacology of nomegestrol acetate

Maturitas, 2012-04, Vol.71 (4), p.345-353

2012

Volltextzugriff (PDF)

May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?

Gynecological endocrinology, 2016-01, Vol.32 (1), p.58-60

2016

Volltextzugriff (PDF)

Hyperandrogenemia and ovarian reserve in patients with Mayer–Rokitansky–Küster–Hauser syndrome type 1 and 2: potential influences on ovarian stimulation

Archives of gynecology and obstetrics, 2018-02, Vol.297 (2), p.513-520

2018

Volltextzugriff (PDF)

Pregnancy-associated breast cancer: maternal breast cancer survival over 10 years and obstetrical outcome at a university centre of women’s health

Archives of gynecology and obstetrics, 2018-08, Vol.298 (2), p.363-372

2018

Volltextzugriff (PDF)

The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case–control studies

Archives of gynecology and obstetrics, 2015-05, Vol.291 (5), p.1141-1146

2015

Volltextzugriff (PDF)

Oestetrol stimulates proliferation and oestrogen receptor expression in breast cancer cell lines: Comparison of four oestrogens

The European journal of contraception & reproductive health care, 2015-02, Vol.20 (1), p.29-35

2015

Volltextzugriff (PDF)

Sexual Function, Contraception, Relationship, and Lifestyle in Female Medical Students

Journal of women's health (Larchmont, N.Y. 2002), 2017-02, Vol.26 (2), p.169

2017

Volltextzugriff (PDF)

Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students

Contraception (Stoneham), 2010-08, Vol.82 (2), p.155-159

2010

Volltextzugriff (PDF)

Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1

Maturitas, 2013-10, Vol.76 (2), p.129-133

2013

Volltextzugriff (PDF)

Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women

Maturitas, 2004-11, Vol.49 (3), p.189-203

2004

Volltextzugriff (PDF)

Are hormonal components of oral contraceptives associated with impaired female sexual function? A questionnaire-based online survey of medical students in Germany, Austria, and Switzerland

Archives of gynecology and obstetrics, 2015-10, Vol.292 (4), p.883-890

2015

Volltextzugriff (PDF)

Breast cancer: Are oestrogen metabolites carcinogenic?

Maturitas, 2007-05, Vol.57 (1), p.42-46

2007

Volltextzugriff (PDF)

Effects of estradiol and progestogens on tumor-necrosis factor-[alpha]-induced changes of biochemical markers for breast cancer growth and metastasis

Gynecological endocrinology, 2008-10, Vol.24 (10), p.576

2008

Volltextzugriff (PDF)

Progestogens and target tissues: Vascular systems

Maturitas, 2009-04, Vol.62 (4), p.356-361

2009

Volltextzugriff (PDF)

Use of dydrogesterone in hormone replacement therapy

Maturitas, 2009-12, Vol.65, p.S51-S60

2009

Volltextzugriff (PDF)

Estradiol metabolism and malignant disease

Maturitas, 2002-09, Vol.43 (1), p.1-10

2002

Volltextzugriff (PDF)

Why use of dienogest for the first contraceptive pill with estradiol?

Gynecological endocrinology, 2010-02, Vol.26 (2), p.109-113

2010

Volltextzugriff (PDF)

The World Health Organization defines hormone replacement therapy as carcinogenic: Is this plausible?

Gynecological endocrinology, 2008-01, Vol.24 (3), p.129-132

2008

Volltextzugriff (PDF)

Effects of dydrogesterone on the vascular system

Gynecological endocrinology, 2007-10, Vol.23 (S1), p.2-8

2007

Volltextzugriff (PDF)

Biochemical markers surrogating on vascular effects of sex steroid hormones

Gynecological endocrinology, 2006-03, Vol.22 (3), p.163-173

2006

Volltextzugriff (PDF)

Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation

Maturitas, 2004-11, Vol.49 (3), p.235-240

2004

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieMenopause

ThemaObstetrics & Gynecology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells

The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells

The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model

Membrane-initiated effects of Serelys ® on proliferation and apoptosis of human breast cancer cells

The pharmacology of nomegestrol acetate

May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?

Hyperandrogenemia and ovarian reserve in patients with Mayer–Rokitansky–Küster–Hauser syndrome type 1 and 2: potential influences on ovarian stimulation

Pregnancy-associated breast cancer: maternal breast cancer survival over 10 years and obstetrical outcome at a university centre of women’s health

The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case–control studies

Oestetrol stimulates proliferation and oestrogen receptor expression in breast cancer cell lines: Comparison of four oestrogens

Sexual Function, Contraception, Relationship, and Lifestyle in Female Medical Students

Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students

Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1

Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women

Are hormonal components of oral contraceptives associated with impaired female sexual function? A questionnaire-based online survey of medical students in Germany, Austria, and Switzerland

Breast cancer: Are oestrogen metabolites carcinogenic?

Effects of estradiol and progestogens on tumor-necrosis factor-[alpha]-induced changes of biochemical markers for breast cancer growth and metastasis

Progestogens and target tissues: Vascular systems

Use of dydrogesterone in hormone replacement therapy

Estradiol metabolism and malignant disease

Why use of dienogest for the first contraceptive pill with estradiol?

The World Health Organization defines hormone replacement therapy as carcinogenic: Is this plausible?

Effects of dydrogesterone on the vascular system

Biochemical markers surrogating on vascular effects of sex steroid hormones

Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation

Aktive Filter

Suchergebnisse filtern